New drug cocktail shows promise for tough pancreatic cancer
Disease control
Completed
This phase 2 trial tested a new drug called onvansertib combined with standard chemotherapy for people with metastatic pancreatic cancer that had already been treated once. The study enrolled 41 adults and measured how many patients' tumors shrank. The goal is to find a better se…
Phase: PHASE2 • Sponsor: Cardiff Oncology • Aim: Disease control
Last updated Jun 27, 2026 08:06 UTC